Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VERxVE: Nevirapine XR vs IR in HIV-1
NCT00561925Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2007
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 21
01
Overview
A Phase 3 trial of nevirapine in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Boehringer Ingelheim. Started Nov 2007; status: completed.
02
Drugs
nevirapine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT00561925.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00561925.